We generated Umod knock‐in (KI) mice carrying these p.C170Y and p.R185S UMOD mutations and investigated the impact of allelic and gene dosage effects on the formation of intracellular aggregates, the role of wild‐type uromodulin and the downstream signaling pathways leading to CKD. This evidence concerns the gene UMOD and chronic kidney disease.